News

Filter

Current filters:

LucentisRituxan

1 to 9 of 19 results

Genentech's share price drops despite 12% growth in 4th-qtr income

21-01-2008

A 12% hike, to $737.0 million, in earnings and a 9% rise in revenues to $2.97 billion for the fourth...

AvastinbevacizumabGenentechLucentisRanibizumab InjectionRituxanrituximab

1 to 9 of 19 results

Back to top